Article

New Issue Alert: CURE Spring

We've got a sneak peek at what’s inside CURE®'s spring issue.

Does cannabis have a positive effect on patients with cancer? Although researchers are still conducting studies to gain further evidence, its popularity is driving its legalization for therapeutic use. Our cover story, Flower Power, covers all the angles.

Next, patients with head and neck cancer are Keeping the Options Open. Learn about the less toxic treatment choices that are moving to be used as initial therapy for patients ­— and, hopefully, improving their quality of life.

And, at the age of 21, one woman was told she had the BRCA1 gene mutation, which meant she had a 55 to 85 percent lifetime risk of developing breast cancer. Years later, and after undergoing a double, prophylactic mastectomy, she learned she was misdiagnosed. Her story, plus how she’s Making Lemonade from life’s lemons.

To read these stories and more, visit curetoday.com/publications and click on the latest CURE® cover. Or, ensure you don’t miss a story when you subscribe to new issue alerts. Visit curetoday.com/email-profile for more information.

And, as always, thanks for reading.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content